Ausdal Financial Partners, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1667146
Davenport, IA
Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$433,450
-$69,037 QoQ
Shares Held
561
-13.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $2,218,484 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
12,894 | $902,966 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
854 | $424,207 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,725 | $385,134 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
8,991 | $281,058 | |
| 5 | ABCL |
AbCellera Biologics Inc.
|
15,167 | $119,060 | |
| 6 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 7 | MNKD |
Mannkind Corp
|
10,507 | $44,759 | |
| 8 | ONCY |
Oncolytics Biotech Inc
|
12,000 | $11,400 |
All Filings in REGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $433,450 | 561 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $502,487 | 651 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||